About Alpha/beta-tubulin-N-acetyltransferase 9
Alpha/beta-tubulin-N-acetyltransferase 9 (NAT9) is a protein
from Homo sapiens identified by UniProt accession
Q9BTE0, 207 residues long.
MolForge cross-references it against 0 known binders and
25 disease associations.
Target properties
| Protein name | Alpha/beta-tubulin-N-acetyltransferase 9 |
| UniProt accession | Q9BTE0 |
| Gene | NAT9 |
| Organism | Homo sapiens |
| Length | 207 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (25)
Diseases linked to this target (Open Targets).
- monocyte count · score 0.20
- Red cell distribution width · score 0.19
- monocyte percentage of leukocytes · score 0.19
- basophil count · score 0.17
- serum gamma-glutamyl transferase measurement · score 0.15
- myeloid white cell count · score 0.05
- neutrophil count · score 0.05
- leukocyte count · score 0.04
- lymphocyte percentage of leukocytes · score 0.02
- psoriasis · score 0.01
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9BTE0-F1 | alphafold | PREDICTED | 92.13 | — |
Amino-acid sequence (207 residues)
MRLNQNTLLL GKKVVLVPYT SEHVPSRYHE WMKSEELQRL TASEPLTLEQ EYAMQCSWQE DADKCTFIVL DAEKWQAQPG ATEESCMVGD VNLFLTDLED LTLGEIEVMI AEPSCRGKGL GTEAVLAMLS YGVTTLGLTK FEAKIGQGNE PSIRMFQKLH FEQVATSSVF QEVTLRLTVS ESEHQWLLEQ TSHVEEKPYR DGSAEPC
Explore Alpha/beta-tubulin-N-acetyltransferase 9 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets